FULMAPA
LIVE

Serial Number

79233936

Owner

Novartis AG

Filing Date

May 8, 2018

Add to watchlist:

No watchlists yet
View on USPTO

FULMAPA Trademark

Serial Number: 79233936 • Registration: 5619795

FULMAPA is a trademark filed by Novartis AG on May 8, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

May 8, 2018

Registration Date

December 4, 2018

Published for Opposition

September 18, 2018

Cancellation Date

June 20, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 20, 2026 INTR
CANCELLED SECTION 71
Jun 20, 2025 C71T
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 16, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 3, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Nov 2, 2018 GPNX
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2018 OP2R
NOTICE OF PUBLICATION
Aug 29, 2018 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 5, 2018 PBCR
NOTICE OF PUBLICATION
Jul 4, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 19, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 7, 2018 SDRC